Paclitaxel in Treating Patients With Metastatic, Recurrent, or Unresectable Cancer of the Esophagus
Public ClinicalTrials.gov record NCT00003326. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Trial of Paclitaxel (TAXOL) Administered as a Weekly One Hour Infusion in Patients With Advanced Esophageal Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of paclitaxel in treating patients with metastatic, recurrent, or unresectable cancer of the esophagus.
Study identification
- NCT ID
- NCT00003326
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 100 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 1997 (Type not available)
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Jul 24, 2008
Started 1997
United States locations
- U.S. sites
- 30
- U.S. states
- 19
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cancer Center of Southern Alabama | Mobile | Alabama | 36607 | — |
| Loma Linda University Medical Center | Loma Linda | California | 92354 | — |
| Veterans Affairs Medical Center - San Francisco | San Francisco | California | 94121 | — |
| Veterans Affairs Medical Center - Washington, DC | Washington D.C. | District of Columbia | 20422 | — |
| Florida Cancer Specialists | Fort Myers | Florida | 33901 | — |
| Savannah Hematology Oncology Associates | Savannah | Georgia | 31405 | — |
| Northwest Medical Specialists, P.C. | Arlington Heights | Illinois | 60004 | — |
| Michiana Hematology/Oncology P.C. | South Bend | Indiana | 46617 | — |
| Siouxland Hematology-Oncology | Sioux City | Iowa | 51101-1733 | — |
| Louisiana Oncology Associates | Lafayette | Louisiana | 70506 | — |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | — |
| Memorial Hospital | Worcester | Massachusetts | 01605 | — |
| Missoula Medical Oncology P.C. | Missoula | Montana | 59802 | — |
| Nevada Cancer Center | Las Vegas | Nevada | 89109 | — |
| University of Medicine and Dentistry of New Jersey - MOBILE | Newark | New Jersey | 07103 | — |
| NYU School of Medicine's Kaplan Comprehensive Cancer Center | New York | New York | 10016 | — |
| Memorial Sloan-Kettering Cancer Center | New York | New York | 10021 | — |
| Rochester General Hospital | Rochester | New York | 14621 | — |
| Albert Einstein Comprehensive Cancer Center | The Bronx | New York | 10461 | — |
| New York Medical College | Valhalla | New York | 10595 | — |
| Duke Comprehensive Cancer Center | Durham | North Carolina | 27710 | — |
| Pitt County Memorial Hospital | Greenville | North Carolina | 27835-6028 | — |
| Akron City Hospital | Akron | Ohio | 44309 | — |
| Hollings Cancer Center | Charleston | South Carolina | 29403 | — |
| Palmetto Hematology/Oncology Associates | Spartanburg | South Carolina | 29303 | — |
| Harrington Cancer Center | Amarillo | Texas | 79106 | — |
| Lone Star Oncology | Austin | Texas | 78759 | — |
| Oncology Consultants | Houston | Texas | 77024 | — |
| University of Texas - MD Anderson Cancer Center | Houston | Texas | 77030-4009 | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00003326, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 24, 2008 · Synced Oct 31, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00003326 live on ClinicalTrials.gov.